Benchmark Report for Clinical Operations Professionals:

Plan your global clinical trials with clarity not based on assumptions

Plan global clinical trials based on official, evidence-based timelines
Identify hidden risks before they impact your clinical trial
Make faster, better-informed strategic decisions

Your Benchmark Report for 0 €Click here

Benchmark_Global_Clinical_Trial_Timelines

The Global Clinical Trial Approval and Startup Timelines

Are perfect for you, if ...

You plan or manage global clinical trials

… and need reliable timeline guidance across multiple countries instead of fragmented information.

You want to avoid unexpected delays in clinical trial startup,
… especially in ethics review, contracting, and site activation where timelines are not clearly defined.

You are responsible for clinical operations or clinical trial timelines

… and are under pressure to deliver clinical trials on time despite operational complexity and uncertainty.

You work in a small biotech or pharma company

… and lack internal benchmarking data or structured regulatory insight to support your planning decisions.

You need to make faster, evidence-based decisions

… and want to replace any assumptions with clear, country-specific regulatory timelines and comparisons.

You want a structured, practical tool and not another theoretical report

… that helps you translate regulatory timelines into real-world planning and execution.

What are you waiting for?

Get Global Clinical Trial Approval and Startup Timelines

for 25+ countries

Download your Benchmark Report Now for 0 €Click here

Enter your text here...

Why do you need a Global Benchmark of

Global Clinical Trial Approval and Startup Timelines?

Because in global clinical trials, time is not only defined by regulations. Iit is defined by complexity.

And this complexity is often invisible during planning.

The reality: You are planning with incomplete information

Most Clinical Operations teams rely on:

High-level regulatory timelines
Internal experience from previous clinical trials
Fragmented insights from CROs or local partners

But this creates a critical gap. You plan based on what is documented, while execution depends on what is not documented.

The problem: Global trials are not standardised

Every country follows a different model:

Parallel vs. integrated approvals
Defined vs. undefined ethics timelines
Structured vs. operationally driven site activation

Without a structured benchmark, it becomes difficult to:

Compare countries objectively
Build realistic startup timelines
Identify dependencies between processes

The consequence: Delays become predictable but remain unmanaged

This leads to:

Unrealistic planning assumptions
Unexpected delays during ethics review and site setup
Misalignment across stakeholders
Increased operational and timeline risk

This challenge is particularly relevant for small and mid-sized biotech teams who often lack internal benchmarking data and structured regulatory insight.

The solution: A structured, evidence-based benchmark

A global benchmark provides you with:

A clear overview of regulatory timelines across countries
Transparency on where timelines are defined and where they are not
A structured comparison of global approval models
A practical foundation for better planning and decision-making

What changes when you use a benchmark?

Instead of reacting to delays, you can:

Plan with realistic expectations
Identify risks before they impact your clinical trial
Align stakeholders with confidence
Improve overall clinical trial execution

In short:

You need a global benchmark because clinical trial timelines are not only regulatory but operational, global, and interconnected.

And without a structured overview, you are planning in uncertainty.

Secure your Global Clinical Trial Timelines for 0 €

Download Now

About the Editor

My name is Jessica Cordes and for more than 15 years I have been working in Clinical Operations like you. When working for small biotech companies, I have been challenged as well with the evolving GCP requirements of the last decade.

You can plan your global clinical trials based on clear, official timelines and structured insights, or continue working with assumptions that lead to unexpected delays.

In my benchmark report, you will therefore find a comprehensive overview of global clinical trial approval and startup timelines, enabling you to understand regulatory frameworks, identify timeline and process variability, and improve your planning across 25+ countries.

Do you have (like most Clinical Operations professionals) limited time or resources to analyse timelines country by country?

Or do you lack clarity on how regulatory, ethics, and operational timelines interact in a real-world clinical trial setup?

Then the benchmark report is the right tool for you.

Start planning with confidence and secure your copy.